Wolverine Blend (BPC-157 + TB-500) 15mg — Vial Spec, Reconstitution Math & COA

Overview of Wolverine Blend (BPC-157 + TB-500) 15mg Specifications & Availability

The 15mg Wolverine Blend vial represents a combined high-concentration peptide format engineered specifically for institutional laboratories conducting extended preclinical trials. Containing a precise stoichiometric mass ratio—typically allocated as 7.5mg of BPC-157 and 7.5mg of TB-500—this compound allows investigators to evaluate dual-pathway tissue remodeling signaling without cross-contaminating individual raw stock vials. Principal investigators select this larger mass spec to maintain standardized molarity across large sample series, reducing inter-assay variance in high-density multi-well assays.

Please note: PX1 Research maintains a dynamic inventory of specialized formulations. While high-mass custom configurations are regularly synthesized for contract lab accounts, our primary standard inventory offering features the Wolverine Blend 10mg (5mg BPC-157 / 5mg TB-500). Researchers seeking alternative total mass vials or raw individual peptides can browse our complete catalog via all peptides or consult our wholesale lab representative team for bulk batch allocations. Every fill size supplied by PX1 Research strictly adheres to identical manufacturing standards, utilizing USA-manufactured processes in ISO 17025 accredited facilities.

Synergistic Molecular Mechanisms: Dual-Pathway Extracellular Signaling

In vitro and animal model studies indicate that combining BPC-157 and TB-500 engages complementary biochemical pathways involved in cellular migration, focal adhesion formation, and microvascular sprouting. BPC-157 (Body Protection Compound 157) is a synthetic 15-amino-acid peptide derived from human gastric juice sequence motifs. Preclinical research demonstrates that BPC-157 upregulates the expression of VEGFR2 (vascular endothelial growth factor receptor 2) and accelerates the FAK-paxillin pathway, promoting fibroblast activation and extracellular matrix (ECM) structural stabilization under oxidative stress.

Conversely, TB-500 is a synthetic fragment corresponding to the active region of Thymosin Beta-4 (specifically amino acids 17–24, LKKTET Q). Preclinical studies suggest that TB-500 primary activities center on actin sequestration, downregulating G-actin polymerization into F-actin to facilitate rapid cellular motility and endothelial cell migration into damaged tissue matrices. When co-administered in cell culture assays, researchers observe a dual-action phenomenon: BPC-157 establishes structural growth factor signaling and collagen deposition pathways, while TB-500 enhances cellular mobility and microvascular architecture formation. Detailed biochemical summaries of these individual targets are detailed within our open-access research library.

Reconstitution Mathematics for 15mg Lyophilized Vials

Accurate reconstitution math is critical when managing a 15mg total mass vial to ensure exact target concentrations during micro-pipetting protocols. When working with a 15mg combined vial (containing 7.5mg BPC-157 and 7.5mg TB-500), adding standard diluent volumes like Bacteriostatic Water (0.9% Benzyl Alcohol) yields predictable concentration gradients across total peptide mass. Investigators can utilize our interactive reconstitution calculator to verify custom volumetric equations prior to fluid addition.

Below are the primary concentration calculations based on standard diluent volumes added directly to a 15mg solid cake:

• 1.0 mL Diluent Addition: Yields a total peptide concentration of 15.0 mg/mL (15.0 µg/µL combined; 7.5 µg/µL BPC-157 / 7.5 µg/µL TB-500). This high-density ratio is ideal for micro-volume microplate loading.

• 2.0 mL Diluent Addition: Yields a total peptide concentration of 7.5 mg/mL (7.5 µg/µL combined; 3.75 µg/µL BPC-157 / 3.75 µg/µL TB-500). Preferred for standardized bench titration models.

• 3.0 mL Diluent Addition: Yields a total peptide concentration of 5.0 mg/mL (5.0 µg/µL combined; 2.5 µg/µL BPC-157 / 2.5 µg/µL TB-500). Provides optimal volumetric margin for multi-point dose-response preclinical protocols.

Reconstitution should always be conducted by directing the diluent flow against the glass vial wall rather than directly onto the lyophilized cake to prevent shear stress degradation of the tertiary peptide structures.

Aliquot Planning and Long-Term Storage Stability

Once reconstituted, high-mass peptide vials present unique stability considerations. Repeated freeze-thaw cycles degrade peptide bonds, resulting in fragment breakdown and compromised assay accuracy. For a 15mg vial, laboratory protocols strongly advise immediate aliquot planning post-reconstitution. Using sterile, low-binding polypropylene micro-centrifuge tubes, researchers should partition the reconstituted solution into single-use volumetric fractions tailored to scheduled assay intervals.

In lyophilized powder form, Wolverine Blend vials maintain chemical integrity for up to 24 months when stored at -20°C in a dry, dark environment. Once reconstituted in sterile bacteriostatic water, the working solution should be stored at 2°C to 8°C and evaluated within 28 days. If long-term liquid storage is required, aliquoted sub-vials must be flash-frozen at -80°C. PX1 Research packs each shipment with cold-chain safeguards to ensure pristine arrival from our distribution hubs in California and Arizona.

Analytical Quality Control: Verification, Purity & Endotoxin Standards

PX1 Research enforces stringent quality control protocols for every peptide batch synthesized. High-throughput multi-peptide blends like the Wolverine Blend require rigorous post-lyophilization testing to confirm that both peptide components remain fully intact, un-degraded, and present in precise stoichometric balance. Each production lot undergoes analytical High-Performance Liquid Chromatography (HPLC) to verify molecular purity exceeding 99%, paired with Mass Spectrometry (MS) to validate exact target molecular weights.

Furthermore, because cellular culture assays and in vivo preclinical models are highly sensitive to bacterial contaminants, every lot undergoes chromogenic LAL testing to guarantee endotoxin levels remain strictly below <0.01 EU/mg. Principal investigators can view, download, and archive lot-matched documentation directly from our centralized COA verification hub. We manufacture all compounds in GMP-compliant facilities adhering to ISO 17025 laboratory standards, providing total confidence for published research compliance.

Comparative Analysis: Wolverine Blend vs. Individual Peptides in Research

Selecting between a pre-mixed combination matrix and individual isolated research peptides depends entirely on experimental design. Single-compound protocols utilizing isolated BPC-157 or isolated TB-500 allow researchers to isolate specific receptor cascades, such as isolating focal adhesion kinase activity without modulating actin-monomer sequestration. In contrast, dual-blend formulations reduce pipetting steps, minimize vial handling errors, and simulate systemic co-activation environments.

When evaluating tissue matrix remodeling pathways, researchers also frequently compare the Wolverine Blend against other cellular repair research compounds. For instance, GHK-Cu focuses primarily on gene expression modulation for collagen synthesis and matrix metalloproteinase regulation, whereas the Wolverine Blend prioritizes rapid cell migration and microvascular endothelial organization. Combining or contrasting these distinct mechanisms provides a broader scope for comparative musculoskeletal research.

Determining Optimal Vial Size: 15mg vs. 10mg Formats

Choosing the ideal vial format requires balancing planned experimental volume against solution stability windows. The 15mg vial is specifically designed for high-throughput screening environments, automated pipetting platforms, or multi-animal cohort studies where large volumes of working solution are consumed rapidly over a brief duration.

For smaller scale in vitro protocols, exploratory pilot studies, or individual assay setups, the standard 10mg Wolverine Blend is often the superior operational choice. Opening smaller vial masses limits the storage duration of reconstituted liquid solutions, preventing potential hydrolytic degradation over extended laboratory timelines. Both formats offer identical purity, analytical validation, and USA-manufactured quality assurance.

Laboratory Equipment & Safe Handling Protocols

All handling of the Wolverine Blend 15mg compound must be conducted by qualified laboratory personnel within a certified biosafety cabinet or laminar flow hood. Standard personal protective equipment (PPE)—including nitrile gloves, lab coats, and splash-resistant eye protection—is mandatory during reconstitution and pipetting steps. Avoid aerosol generation during liquid transfers.

This research product is supplied strictly for in vitro laboratory evaluation, biochemical assays, and preclinical animal research models. It is not approved, designed, or labeled for human consumption, clinical application, or veterinary therapeutic use. Adherence to institutional environmental health and safety (EHS) disposal guidelines for synthetic peptides and non-hazardous biochemical waste is strictly required.